T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
2026
DELISTED
Flushing Financial
FFIC
| $750K | ﹤0.01% |
59,419
+7,672
| +15% | +$108K |
|
2027
West Bancorporation
WTBA
$511M
| $749K | ﹤0.01% |
41,994
+647
| +2% | +$11.9K |
|
2028
Ironwood Pharmaceuticals
IRWD
$674M
| $746K | ﹤0.01% |
85,577
+4,993
| +6% | +$60.6K |
|
|
VMEO
2029
DELISTED
Vimeo
VMEO
| $743K | ﹤0.01% |
181,579
+5,776
| +3% | +$24.6K |
|
|
BRKL
2030
DELISTED
Brookline Bancorp
BRKL
| $742K | ﹤0.01% |
74,413
+3,040
| +4% | +$30.7K |
|
2031
Janux Therapeutics
JANX
$978M
| $739K | ﹤0.01% |
+19,596
| New | +$427K |
|
2032
Worthington Steel
WS
$1.94B
| $739K | ﹤0.01% |
20,612
+1,041
| +5% | +$31.6K |
|
2033
Vicor
VICR
$10.4B
| $736K | ﹤0.01% |
19,229
+2,535
| +15% | +$98.5K |
|
|
BBT
2034
Beacon Financial Corp
BBT
$2.71B
| $734K | ﹤0.01% |
31,988
+1,753
| +6% | +$40.1K |
|
2035
Bumble
BMBL
$359M
| $734K | ﹤0.01% |
64,626
+3,683
| +6% | +$47K |
|
|
GES
2036
DELISTED
Guess Inc
GES
| $734K | ﹤0.01% |
23,315
+1,076
| +5% | +$26.5K |
|
|
VSTO
2037
DELISTED
Vista Outdoor Inc.
VSTO
| $734K | ﹤0.01% |
22,387
+2,084
| +10% | +$63.2K |
|
|
HAYN
2038
DELISTED
Haynes International, Inc.
HAYN
| $733K | ﹤0.01% |
12,184
+541
| +5% | +$31.2K |
|
2039
Sonic Automotive
SAH
$2.51B
| $730K | ﹤0.01% |
12,806
+458
| +4% | +$24.3K |
|
2040
Nelnet
NNI
$4.55B
| $729K | ﹤0.01% |
7,699
+497
| +7% | +$43.7K |
|
|
BRSP
2041
BrightSpire Capital
BRSP
$629M
| $727K | ﹤0.01% |
105,399
+4,269
| +4% | +$29.8K |
|
|
UHT
2042
Universal Health Realty Income Trust
UHT
$573M
| $726K | ﹤0.01% |
19,751
+4,490
| +29% | +$178K |
|
|
DMC
2043
Del Monte Corp
DMC
$1.44B
| $722K | ﹤0.01% |
27,856
+1,471
| +6% | +$36.6K |
|
2044
Customers Bancorp
CUBI
$2.82B
| $721K | ﹤0.01% |
13,576
+1,030
| +8% | +$54.2K |
|
2045
Hackett Group
HCKT
$277M
| $720K | ﹤0.01% |
29,595
+2,175
| +8% | +$51.6K |
|
2046
Center Bancorp
CNOB
$1.81B
| $719K | ﹤0.01% |
36,860
+1,535
| +4% | +$32.2K |
|
2047
NVE Corp
NVEC
$563M
| $719K | ﹤0.01% |
7,966
+237
| +3% | +$19.1K |
|
2048
National Healthcare
NHC
$3.44B
| $716K | ﹤0.01% |
7,573
+439
| +6% | +$41.6K |
|
2049
Sotera Health
SHC
$5.43B
| $715K | ﹤0.01% |
59,480
+12,195
| +26% | +$181K |
|
2050
Artivion
AORT
$1.39B
| $713K | ﹤0.01% |
33,690
+1,634
| +5% | +$30.4K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.